News
Tuesday, July 29, 2025
TrilliumBiO and T-NeuroDx Announce Strategic Collaboration to Commercialize Blood-Based Biomarkers for Alzheimer's Disease
Partnership aims to accelerate the validation and commercialization of non-invasive diagnostic tools for earlier and more accessible detection of Alzheimer's disease ROCKVILLE, Md., July 29, 2025 /PRNewswire/ -- TrilliumBiO, a leader in biomarker discovery and precision diagnostics, today announced a strategic collaboration with T-NeuroDx, a pioneering diagnostics company dedicated to developing innovative solutions for detecting neurodegenerative diseases, to advance the development of blood-based
